sternekessler documents

SKGF_Presentation_IP Issues in Nanotechnology - A View from Around the World_2004
Documents SKGF_Presentation_IP Issues in Nanotechnology - A View from Around the World_2004
SKGF_Advisory_Living in a Post KSR World_2007
Technology SKGF_Advisory_Living in a Post KSR World_2007
SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007
Technology SKGF_Presentation_The Supreme Courts Renewed Interest In IP_April 2007
SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes And Other Reform Initiatives_2006
Technology SKGF_Presentation_What You Need To Know About The Proposed USPTO Rule Changes And Other Reform Initiatives_2006
SKGF_Advisory_USPTO Proposed Rule Changes Impact on Small Business_2006
Technology SKGF_Advisory_USPTO Proposed Rule Changes Impact on Small Business_2006
SKGF_Advisory_Therapeutic Antibodies Top Three Intellectual Property Issues_2008
Technology SKGF_Advisory_Therapeutic Antibodies Top Three Intellectual Property Issues_2008
SKGF_Advisory_The Impact of Patent Reform on Nanotech_2006
Technology SKGF_Advisory_The Impact of Patent Reform on Nanotech_2006
SKGF_Advisory_Consider a Prosecution History Disclaimer for Every Continuation Application_2007
Technology SKGF_Advisory_Consider a Prosecution History Disclaimer for Every Continuation Application_2007
SKGF_Presentation_Left Turns Only - Making Sense of Nanotech IP Strategy_2004
Technology SKGF_Presentation_Left Turns Only - Making Sense of Nanotech IP Strategy_2004
SKGF_Presentation_Computer-Related Patent Law, Strategy and Trends - Release 1.8_2004
Documents SKGF_Presentation_Computer-Related Patent Law, Strategy and Trends - Release 1.8_2004
SKGF_Advisory_Strategies for Life Under the New USPTO Rules on Continuation and Claims Practice_2007
Technology SKGF_Advisory_Strategies for Life Under the New USPTO Rules on Continuation and Claims Practice_2007
SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007
Health & Medicine SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007
SKGF_Presentation_SKGF Nanotube Patent Study_2004
Technology SKGF_Presentation_SKGF Nanotube Patent Study_2004
SKGF_Presentation_Patenting Antibodies_2006
Documents SKGF_Presentation_Patenting Antibodies_2006
SKGF_Presentation_Optimizing Reexamination Patent Strategy at the U.S. Patent Office for your IP Business Model_2008
Documents SKGF_Presentation_Optimizing Reexamination Patent Strategy at the U.S. Patent Office for your IP Business Model_2008
SKGF_Presentation_Patent Licensing in the Wake of MedImmune, eBay, KSR and Microsoft_2007
Documents SKGF_Presentation_Patent Licensing in the Wake of MedImmune, eBay, KSR and Microsoft_2007
SKGF_Presentation_Stem Cells The Patent Landscape_2005
Technology SKGF_Presentation_Stem Cells The Patent Landscape_2005
SKGF_Presentation_USPTO Patent Examination Reform and Proposed Rule Changes-2006
Documents SKGF_Presentation_USPTO Patent Examination Reform and Proposed Rule Changes-2006
SKGF_Presentation_Biosimilars: Where Do We Stand and Where Are We Headed?_2008
Technology SKGF_Presentation_Biosimilars: Where Do We Stand and Where Are We Headed?_2008
SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal Maze_06
Documents SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal Maze_06
SKGF_Presentation_The Role of Formulations in Biologics Patent Protection_08
Technology SKGF_Presentation_The Role of Formulations in Biologics Patent Protection_08